As transplantation of hMSCs in stroke models has been associated not only with a decrease in inflammation, but also reduced scarring [5], [15], we analyzed the effect of cell transplantation on scar formation by immunostaining against fibronectin and NG2-CSP. This evidence concerns the gene FN1 and stroke disorder.